These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34938188)

  • 21. Cyanobacterial metabolites as promising drug leads against the M
    Naidoo D; Roy A; Kar P; Mutanda T; Anandraj A
    J Biomol Struct Dyn; 2021 Oct; 39(16):6218-6230. PubMed ID: 32691680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.
    Goyal B; Goyal D
    ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural basis for the inhibition of coronaviral main proteases by PF-00835231.
    Zhou X; Lu X; Lin C; Zou X; Li W; Zeng X; Wang J; Zeng P; Wang W; Zhang J; Jiang H; Li J
    Acta Biochim Biophys Sin (Shanghai); 2024 Jul; ():. PubMed ID: 39076076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of NO donor furoxan as SARS-CoV-2 main protease (M
    Al-Sehemi AG; Pannipara M; Parulekar RS; Patil O; Choudhari PB; Bhatia MS; Zubaidha PK; Tamboli Y
    J Biomol Struct Dyn; 2021 Sep; 39(15):5804-5818. PubMed ID: 32643550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalytic Dyad Residues His41 and Cys145 Impact the Catalytic Activity and Overall Conformational Fold of the Main SARS-CoV-2 Protease 3-Chymotrypsin-Like Protease.
    Ferreira JC; Fadl S; Villanueva AJ; Rabeh WM
    Front Chem; 2021; 9():692168. PubMed ID: 34249864
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Wen L; Tang K; Chik KK; Chan CC; Tsang JO; Liang R; Cao J; Huang Y; Luo C; Cai JP; Ye ZW; Yin F; Chu H; Jin DY; Yuen KY; Yuan S; Chan JF
    Int J Biol Sci; 2021; 17(6):1555-1564. PubMed ID: 33907519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease: room-temperature X-ray and neutron crystallography, binding thermodynamics, and antiviral activity.
    Kneller D; Li H; Phillips G; Weiss K; Zhang Q; Arnould M; Jonsson C; Surendranathan S; Parvathareddy J; Blakeley M; Coates L; Louis J; Bonnesen P; Kovalevsky A
    Res Sq; 2022 Feb; ():. PubMed ID: 35169792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detailed Insights into the Inhibitory Mechanism of New Ebselen Derivatives against Main Protease (M
    Sahoo P; Lenka DR; Batabyal M; Pain PK; Kumar S; Manna D; Kumar A
    ACS Pharmacol Transl Sci; 2023 Jan; 6(1):171-180. PubMed ID: 36650888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography.
    Kneller DW; Zhang Q; Coates L; Louis JM; Kovalevsky A
    IUCrJ; 2021 Nov; 8(Pt 6):973-979. PubMed ID: 34804549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M
    Kumar SB; Krishna S; Pradeep S; Mathews DE; Pattabiraman R; Murahari M; Murthy TPK
    Comput Biol Med; 2021 Jul; 134():104524. PubMed ID: 34090015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis.
    Zakharova MY; Kuznetsova AA; Kaliberda EN; Dronina MA; Kolesnikov AV; Kozyr AV; Smirnov IV; Rumsh LD; Fedorova OS; Knorre DG; Gabibov AG; Kuznetsov NA
    Biochimie; 2017 Nov; 142():125-134. PubMed ID: 28843613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microsecond MD Simulation and Multiple-Conformation Virtual Screening to Identify Potential Anti-COVID-19 Inhibitors Against SARS-CoV-2 Main Protease.
    Selvaraj C; Panwar U; Dinesh DC; Boura E; Singh P; Dubey VK; Singh SK
    Front Chem; 2020; 8():595273. PubMed ID: 33585398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural basis of SARS-CoV-2 main protease inhibition by a broad-spectrum anti-coronaviral drug.
    Wang YC; Yang WH; Yang CS; Hou MH; Tsai CL; Chou YZ; Hung MC; Chen Y
    Am J Cancer Res; 2020; 10(8):2535-2545. PubMed ID: 32905393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
    Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
    Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circadian clock modulating small molecules repurposing as inhibitors of SARS-CoV-2 M
    Sultan A; Ali R; Sultan T; Ali S; Khan NJ; Parganiha A
    Chronobiol Int; 2021 Jul; 38(7):971-985. PubMed ID: 33820462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct Observation of Protonation State Modulation in SARS-CoV-2 Main Protease upon Inhibitor Binding with Neutron Crystallography.
    Kneller DW; Phillips G; Weiss KL; Zhang Q; Coates L; Kovalevsky A
    J Med Chem; 2021 Apr; 64(8):4991-5000. PubMed ID: 33755450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The S1'-S3' Pocket of the SARS-CoV-2 Main Protease Is Critical for Substrate Selectivity and Can Be Targeted with Covalent Inhibitors.
    Liu M; Li J; Liu W; Yang Y; Zhang M; Ye Y; Zhu W; Zhou C; Zhai H; Xu Z; Zhang G; Huang H
    Angew Chem Int Ed Engl; 2023 Oct; 62(41):e202309657. PubMed ID: 37609788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide.
    Yamane D; Onitsuka S; Re S; Isogai H; Hamada R; Hiramoto T; Kawanishi E; Mizuguchi K; Shindo N; Ojida A
    Chem Sci; 2022 Mar; 13(10):3027-3034. PubMed ID: 35432850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding Selenium and Glutathione as Antiviral Factors in COVID-19: Does the Viral M
    Taylor EW; Radding W
    Front Nutr; 2020; 7():143. PubMed ID: 32984400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of RevX solution extract as a potential inhibitor of the main protease of SARS-CoV-2-
    Chou FP; Liu CC; Huong Giang HN; Huang SC; Hsu HF; Wu TK
    Heliyon; 2022 Mar; 8(3):e09034. PubMed ID: 35252620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.